Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/293480 stock hub

KRX/293480 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/293480is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

171.2B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/293480

In the news

Latest news · KRX/293480

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E4.3

P25 12P50 23.1P75 39.5

ROE35.5

P25 -17.1P50 0.7P75 8.5

ROIC28.2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/293480 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

KRW

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7293480000
Last refreshed	2026-05-10
Market cap	KRW 171.2B
Price	KRW 9,630
Price currency	KRW
Sector	Healthcare
Sic	2834
Symbol	krx/293480
Website	https://www.hanaph.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	14.2%
FCF yield	8.87%
P/B ratio	2.11x
P/E ratio	4.29x
P/S ratio	1.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.83%
EBITDA Margin	25.36%
FCF margin	10.9%
Gross margin	67.47%
Gross Profit	KRW 94B
Net Income	KRW 24.3B
Net Income Growth Years	0%
Pretax Margin	22.22%
Profit Margin	17.44%
Profitable Years	11
ROA	15.52
ROCE	34.27
ROE	35.53
ROIC	28.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-14.23%
Cagr3y	-10.48%
Cagr5y	-13.44%
Div CAGR3	-20.11%
Div CAGR5	-12.61%
EPS Growth Years	0
Revenue Growth	11.88x
Revenue Growth Quarters	6x
Revenue Growth Years	10x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.09
Assets	KRW 141.6B
Cash	KRW 16.5B
Current Assets	KRW 79.4B
Current Liabilities	KRW 48.7B
Debt	KRW 29B
Debt EBITDA	KRW 0.82
Debt Equity	KRW 0.36
Debt FCF	KRW 1.91
Equity	KRW 81.3B
Interest Coverage	30.47
Liabilities	KRW 60.3B
Long Term Assets	KRW 62.2B
Long Term Liabilities	KRW 11.5B
Net Cash	KRW -12.6B
Net Cash By Market Cap	KRW -7.34
Net Debt EBITDA	KRW 0.36
Net Debt Equity	KRW 0.15
Net Debt FCF	KRW 0.83
Tangible Book Value	KRW 77.6B
Tangible Book Value Per Share	KRW 7,157
WACC	5.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.63
Inventory Turnover	2.43
Net Working Capital	KRW 37B
Quick ratio	1.22
Working Capital	KRW 30.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-49.02%
Dividend Growth Years	0%
Dividend per share	KRW 510
Dividend Years	2
Dividend Yield	5.3%
Ex Div Date	2025-12-29
Last Dividend	KRW 260
Payout Frequency	Annual
Payout Ratio	4.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-14.23%
200-day SMA	11,010.2
3Y total return	-28.26%
50-day SMA	9,582.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-51.39%
All Time High	34,954.5
All Time High Change	-72.45%
All Time High Date	2018-10-02
All Time Low	9,050
All Time Low Change	6.41%
All Time Low Date	2026-04-02
ATR	189.6
Beta	0.38
Beta1y	0.23
Beta2y	0.19
Ch YTD	-14.17
High	9,800
High52	12,500
High52 Date	2025-06-24
High52ch	-22.96%
Low	9,560
Low52	9,050
Low52 Date	2026-04-02
Low52ch	6.41%
Ma50ch	0.49%
Price vs 200-day SMA	-12.54%
RSI	47.95
RSI Monthly	33.61
RSI Weekly	37.49
Sharpe ratio	-0.84x
Sortino ratio	-0.84
Total Return	5.3%
Tr YTD	-14.17
Tr1m	4.9%
Tr1w	-2.23%
Tr3m	-6.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 31.8B
Operating margin	22.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,109,779%
Net Borrowing	-1,879,985,890
Shares Insiders	57.71%
Shares Institutions	0.36%
Shares Out	17,772,946

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 15.2B
Average Volume	31,074.25x
Bv Per Share	7,469.7
CAPEX	KRW -10.2B
Ch1m	4.9
Ch1w	-2.23
Ch1y	-16.11
Ch3m	-6.69
Ch3y	-35.46
Ch5y	-58.67
Ch6m	-14.55
Change	-1.43%
Change From Open	-1.43
Close	9,770
Days Gap	0
Depreciation Amortization	3,521,674,000
Dollar Volume	235,434,240
Earnings Date	2025-11-14
EBIT	KRW 31.8B
EBITDA	KRW 35.3B
EPS	KRW 2,243
F Score	4
FCF	KRW 15.2B
FCF Per Share	KRW 854
Financing CF	-1,010,545,960
Fiscal Year End	December
Founded	1,996
Graham Number	19415.86494
Graham Upside	101.6
Income Tax	KRW 6.7B
Investing CF	-12,818,201,690
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Split Date	2021-04-28
Last Split Type	Forward
Ma150	10,703.7
Ma150ch	-10.03%
Ma20	9,696.5
Ma20ch	-0.69%
Net CF	11,551,418,860
Open	9,770
P FCF Ratio	11.27
P OCF Ratio	6.74
Payment Date	2026-04-29
Position In Range	29.17
Ppne	46,653,103,570
Price Date	2026-05-08
Price EBITDA	KRW 4.84
Ptbv Ratio	2.21
Relative Volume	0.79x
Revenue	139,331,265,570x
Tax By Revenue	4.78x
Tax Rate	21.51%
Tr6m	-12.63%
Volume	24,448
Z Score	2.67

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/293480 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.3%

$510 annual per share

Payout ratio

+4.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-12.6%

0 consecutive years of growth

Total shareholder yield

+5.3%

Next ex-dividend date: 2025-12-29

Performance

KRX/293480 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/293480?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

+57.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/293480 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.0

Neutral momentum band

Price vs 200-day MA

-12.5%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

-0.84

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/293480

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/293480 stock rating?

krx/293480 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/293480 analysis?

The full report lives at /stocks/krx/293480/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/293480?

The latest report frames krx/293480 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/293480 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.